Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN1A | P35498 | 4/20 | 0.51 |
| ▸ | SCN2A | Q99250 | 4/20 | 0.51 |
| ▸ | SCN3A | Q9NY46 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | HTR1A | P08908 | 3/20 | 0.44 |
| ▸ | HTR6 | P50406 | 1/20 | 0.43 |
| ▸ | METAP2 | P50579 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7214875 | 0.86 | HTR1A (0.47) | SCN1ASCN2ASCN3AHTR1ALMNA | |
| SCHEMBL28203264 | 0.86 | KDM4E (0.43) | SCN1ASCN2ASCN3AKDM4EALDH1A1 | |
| SCHEMBL2398894 | 0.85 | FOLH1 (0.56) | SCN1ASCN2ASCN3AKDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL11581395 | 0.83 | SCN1A (0.55) | SCN1ASCN2ASCN3AKDM4EALDH1A1 | |
| SCHEMBL2486332 | 0.83 | TAAR1 (0.50) | KDM4EALDH1A1HPGDHTR1AHTR6 | |
| Hydrochloric Acid SCHEMBL29811165 | 0.81 | TAAR1 (0.49) | KDM4EALDH1A1HPGDHTR1AHTR6 | |
| SCHEMBL8947503 | 0.81 | SCN1A (0.52) | SCN1ASCN2ASCN3AKDM4EALDH1A1 | |
| SCHEMBL10621476 | 0.81 | L3MBTL1 (0.46) | SCN1ASCN2ASCN3AKDM4EALDH1A1 | |
| SCHEMBL334956 | 0.80 | KMT2A (0.47) | KDM4EALDH1A1HPGDMETAP2LMNA | |
| SCHEMBL4735612 | 0.80 | ALDH1A1 (0.54) | KDM4EALDH1A1HPGDMETAP2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020034912-A1 | METHODS AND COMBINATIONS FOR MODULATING TOLERANCE TO OPIATES, OPIOIDS OR OPIOID ANALGESICS AND TREATING ACUTE AND CHRONIC PAIN | HSIEH CHIA HUNG (CN) | 2020-02-20 | — | — | WO | disclosed |
| EP-2696878-A1 | DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA | Cyclacel Limited (GB) | 2014-02-19 | — | — | EP | disclosed |
| EP-1562640-B1 | METHODS FOR PURIFYING RADIOLABELLED COMPOUNDS | UNIV MCMASTER (CA) | 2012-12-05 | — | — | EP | disclosed |
| WO-2012140436-A1 | DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA | CYCLACEL LIMITED (GB) | 2012-10-18 | — | — | WO | disclosed |
| EP-2414543-A1 | GENETIC MARKERS FOR RISK MANAGEMENT OF ATRIAL FIBRILLATION AND STROKE | Decode Genetics EHF (IS) | 2012-02-08 | — | — | EP | disclosed |
| EP-2365809-A1 | PYRAZINOPYRAZINES AND DERIVATIVES AS KINASE INHIBITORS | ARIAD Pharmaceuticals, Inc (US) | 2011-09-21 | — | — | EP | disclosed |
| EP-2307002-A1 | COMBINATIONS OF SAPACITABINE OR CNDAC WITH DNA METHYLTRANSFERASE INHIBITORS SUCH AS DECITABINE AND PROCAINE | Cyclacel Limited (GB) | 2011-04-13 | — | — | EP | disclosed |
| WO-2010056311-A1 | PYRAZINOPYRAZINES AND DERIVATIVES AS KINASE INHIBITORS | ARIAD PHARMACEUTICALS, INC. (US) | 2010-05-20 | — | — | WO | disclosed |
| WO-2009150405-A1 | COMBINATION OF SPACITABINE (CNDAC) AND DNA METHYLTRANSFERASE INHIBITORS SUCH AS DECITABINE AND PROCAINE | CYCLACEL LIMITED (GB) | 2009-12-17 | — | — | WO | disclosed |